Tackling long COVID-19, with safety proven Japanese Beta Glucans; The first clinical report in the world

The first report of Japanese Beta Glucan food supplements yields benefits in Covid-19 patients in the world.
Encouraging outcome of the clinical study has been published in the Biomedicine and Pharmacotherapy journal by Elsevier: (

For further details please visit the press release on Foreign Press Center Japan.


Other Press release

Other articles